Invea Therapeutics Strengthens Leadership with Appointment of Dr. Stephen Doberstein, Veteran Biotech Executive, to Its Board of Directors GUILFORD, Conn., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Invea Therapeutics, Inc. (Invea), a leading biotechnology company developing an artificial intelligence (AI), GenAI, and machine learning (ML)...

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update U.S. FDA clears Investigational New Drug application for THB335 Phase 1 SAD/MAD clinical trial initiated and subject screening underway, with results expected during 1H’25 Strengthened leadership...

ViraCor-IBT Laboratories to Present at the American College of Allergy, Asthma and Immunology's Annual Meeting LENEXA, KS and LEE'S SUMMIT, MO--(Marketwire - November 4, 2009) - Scientists from ViraCor-IBT Laboratories have been selected to provide four oral presentations and one poster presentation at this...